The DOI matches its Crossref record.
Glucose Analog Inhibitors of Glycogen Phosphorylases as Potential Antidiabetic Agents: Recent Developments
Open accessAbstract
Diabetes is among the largest contributors to global mortality through its long term complications. The worldwide epidemic of type 2 diabetes has been stimulating the quest for new concepts and targets for the treatment of this incurable disease. A new target is glycogen phosphorylase (GP), the main regulatory enzyme in the liver responsible for the control of blood glucose levels. One of several approaches to influence the action of GP is the use of glucose derivatives as active site inhibitors. This field of research commenced 10-15 years ago and, due to joint efforts in computer aided molecular design, organic synthesis, protein crystallography, and biological assays, resulted in glucopyranosylidene-spiro-hydantoin 16 (K(i) = 3-4 micro M) as the most efficient glucose analog inhibitor of GP of that time. The present paper surveys the recent developments of this field achieved mainly in the last five years: the synthesis and evaluation of glucopyranosylidene-spiro-thiohydantoin 18 (K(i) = 5 micro M) which has proven equipotent with 16, and is available in gram amounts; furanosylidene- and xylopyranosylidene-spiro-(thio)hydantoins whose ineffectiveness (K(i) > 10 mM) confirmed the high specificity of the catalytic site of GP towards the D-glucopyranosyl unit; "open" hydantoins like methyl N-(1-carboxamido-D-glucopyranosyl)carbamate 37 (K(i) = 16 micro M) and N-acyl-N'-(beta-D-glucopyranosyl)ureas among them the to date best glucose analog inhibitor N-(2-naphthoyl)-N'-(beta-D-glucopyranosyl)urea (35, K(i) = 0.4 micro M) which can also bind to the so-called new allosteric site of GP; C-(beta-D-glucopyranosyl)heterocycles (tetrazole, 1,3,4-oxadiazoles, benzimidazole (K(i) = 11 micro M), and benzothiazole). Iminosugars like isofagomine (45, IC(50) = 0.7 micro M), noeuromycin (53, IC(50) = 4 micro M), and azafagomine (54, IC(50) = 13.5 micro M) also bind strongly to the active site of GP, however, substitution on the nitrogens makes the binding weaker. The natural product five-membered iminosugar DAB (56) exhibited IC(50) approximately 0.4-0.5 micro M. Azoloperhydropyridines which can be regarded iminosugar-annelated heterocycles show moderate inhibition of GP: nojiritetrazole 12 (K(i) = 53 micro M) is the best inhibitor and fewer nitrogens in the five-membered ring weakens the binding. Physiological investigations have been carried out with N-acetyl-beta-D-glucopyranosylamine 6, spiro-thiohydantoin 18, isofagomine 45, and DAB 56 to underline the potential use of these compounds in the treatment of type 2 diabetes. Computational methods suggest to synthesize further anomerically bifunctional glucose derivatives which may be good inhibitors of GP.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cited by
Sorted by citations
Items 101–185 of 185
Czifrák, K., Hadady, Z., Docsa, T., et al. (2006) · Carbohydrate Research · doi:10.1016/j.carres.2006.03.002 · Cited by 19
Self-citationFree-radical and ionic routes towards hydrolytically stable and bioactive C-glycosyl compounds
Chen, G., & Praly, J. (2007) · Comptes Rendus Chimie · doi:10.1016/j.crci.2007.03.006 · Cited by 18
Synthesis of anomeric sulfonamides and their behaviour under radical-mediated bromination conditions
Czifrák, K., & Somsák, L. (2008) · Carbohydrate Research · doi:10.1016/j.carres.2008.11.002 · Cited by 18
Self-citationDesign and syntheses of some iminosugar derivatives as potential immunosuppressants
Zhang, G., Zheng, X., Zhang, L., & Ye, X. (2011) · MedChemComm · doi:10.1039/c1md00098e · Cited by 17
Widowati, W., Maesaroh, M., Fauziah, N., Erawijantari, P. P., & Sandra, F. (2015) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v7i3.180 · Cited by 17
Czifrák, K., Kovács, L., Kövér, K. E., et al. (2005) · Carbohydrate Research · doi:10.1016/j.carres.2005.06.033 · Cited by 17
Self-citationElek, R., Kiss, L., Praly, J., et al. (2005) · Carbohydrate Research · doi:10.1016/j.carres.2005.02.021 · Cited by 17
Self-citationTzanetou, E. N., Kasiotis, K. M., Magiatis, P., et al. (2007) · Molecules · doi:10.3390/12040735 · Cited by 17
“In particular, alkaloid lipids such as (+)-desoxoprosophylline (1, Figure 1) [1] display significant anesthetic, analgesic and antibiotic activities [2-4], while their corresponding iminosugars – exemplified by N-butyl–1–deoxynojirimycin (NB-DNJ, 2) which was recently approved for the treatment of Gaucher disease [5]…”
BackgroundFlexible synthesis and biological evaluation of novel 5-deoxyadenophorine analogues
Pearson-Long, M. S. M., Saad, R. O., Dintinger, T., Amri, H., Mathé‐Allainmat, M., & Lebreton, J. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.03.035 · Cited by 17
Menuel, S., Porwański, S., & Marsura, A. (2006) · New Journal of Chemistry · doi:10.1039/b600023a · Cited by 16
Chrysina, E. D., Kosmopoulou, M. N., Kardakaris, R., et al. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.10.040 · Cited by 16
Binding of oxalyl derivatives of β-d-glucopyranosylamine to muscle glycogen phosphorylase b
Hadjiloi, T., Tiraidis, C., Chrysina, E. D., et al. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.01.045 · Cited by 15
Synthesis, screening and docking of small heterocycles as Glycogen Phosphorylase inhibitors
Schweiker, S. S., Loughlin, W. A., Lohning, A. E., Petersson, M. J., & Jenkins, I. D. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.07.063 · Cited by 14
Evaluation of novel Hyphodermin derivatives as Glycogen Phosphorylase a inhibitors
Loughlin, W. A., Pierens, G. K., Petersson, M. J., et al. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.04.047 · Cited by 14
Design, synthesis and glycosidase inhibition of C-4 branched LAB and DAB derivatives
Wang, J.-Z., Cheng, B., Kato, A., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114230 · Cited by 13
Gregus, Z., & Németi, B. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm212 · Cited by 13
“There are a number of xenobiotics that have been recognized by chance as GPI or developed to specifically inhibit GP for using them as blood glucose–lowering drugs in non-insulin– dependent diabetes (Henke and Sparks, 2006; Somsák et al., 2003; Oikonomakos, 2002; Fig.”
BackgroundArora, I., Sharma, S. K., & Shaw, A. K. (2016) · RSC Advances · doi:10.1039/c5ra26005a · Cited by 12
A Review on Biological Activities of Sugars and Sugar Derivatives
Spriha, S. E., & Rahman, S. A. (2022) · Dhaka University Journal of Pharmaceutical Sciences · doi:10.3329/dujps.v20i3.59803 · Cited by 12
“Structures of some sugar derivative drugs (14-31).”
BackgroundAouadi, K., Lajoix, A., Gross, R., et al. (2008) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200800744 · Cited by 12
Wu, X., Zhang, F., Zhu, J., Song, C., Xiong, D., Zhou, Y., Cui, Y., & Ye, X. (2014) · Chemistry - An Asian Journal · doi:10.1002/asia.201400023 · Cited by 12
Synthesis of a C-glucosylated cyclopropylamide and evaluation as a glycogen phosphorylase inhibitor
Bertus, P., Szymoniak, J., Jeanneau, E., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.07.098 · Cited by 12
Self-citationSynthesis and anticancer activity of Pt(II) complexes of spiro-5-substituted 2,4-dithiohydantoins
Ahmedova, A., Pavlović, G., Marinov, M. N., et al. (2021) · Inorganica Chimica Acta · doi:10.1016/j.ica.2021.120605 · Cited by 11
Ramesh, N. G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816675-8.00008-7 · Cited by 11
A new approach toward the total synthesis of (+)-batzellaside B
Wierzejska, J., Motogoe, S.-I., Makino, Y., et al. (2012) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.8.210 · Cited by 11
Gupta, P., Dharuman, S., & Vankar, Y. D. (2010) · Tetrahedron Asymmetry · doi:10.1016/j.tetasy.2010.11.027 · Cited by 11
Loughlin, W. A., Jenkins, I. D., Karis, N. D., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.01.031 · Cited by 11
The first synthesis of 7-(hydroxymethyl)thiepane-3,4,5-triols from d-(−)-quinic acid
Shih, T., & Gao, W.-L. (2012) · Tetrahedron · doi:10.1016/j.tet.2012.12.047 · Cited by 11
Engineering allosteric regulation into the hinge region of a circularly permuted TEM-1 β-lactamase
Mathieu, V., Fastrez, J., & Soumillion, P. (2010) · Protein Engineering Design and Selection · doi:10.1093/protein/gzq041 · Cited by 11
“Second, specific inhibitors are able to bind in the active site cavity preventing the access of the substrate (Somsák et al., 2003).”
BackgroundFernández-Novell, J. M., & Díaz‐Lobo, M. (2017) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-017-2597-y · Cited by 10
Misra, A. K., Bokor, É., Kun, S., et al. (2015) · Tetrahedron Letters · doi:10.1016/j.tetlet.2015.09.040 · Cited by 10
Self-citationCzifrák, K., Páhi, A., Deák, S., et al. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.05.076 · Cited by 10
Self-citationStraightforward Synthesis of Novel 1-(2′-α-O-D-Glucopyranosyl ethyl) 2-Arylbenzimidazoles
Arumugam, N., Rahim, A. S. A., Hamid, S. A., et al. (2012) · Molecules · doi:10.3390/molecules17089887 · Cited by 9
Glycogen phosphorylase inhibitory effects of 2-oxo-1,2-dihydropyridin-3-yl amide derivatives
Karis, N. D., Loughlin, W. A., Jenkins, I. D., et al. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.04.049 · Cited by 9
Decuyper, L., Piens, N., Mincke, J., Bomon, J., Schrijver, B. D., Mollet, K., Winter, K. D., Desmet, T., & D’hooghe, M. (2016) · RSC Advances · doi:10.1039/c6ra08213k · Cited by 9
Petsalaki, E., Chrysina, E. D., Tiraidis, C., et al. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.03.044 · Cited by 9
Jiang, F.-X., Liu, Q.-Z., Zhao, D., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.03.004 · Cited by 8
Szabó, K., Kandra, L., & Gyémánt, G. (2019) · Carbohydrate Research · doi:10.1016/j.carres.2019.03.014 · Cited by 8
“maltoheptaoside (CNP-G7) and GTH were synthesized at the University of Debrecen [38, 39].”
MethodAltun, Y., Doğan, Ş. D., & Balcı, M. (2014) · Tetrahedron · doi:10.1016/j.tet.2014.05.069 · Cited by 8
Mallick, A., & Vankar, Y. D. (2014) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201402142 · Cited by 7
Hypoglycemic Potential of Benzimidazole Derivatives
Спасов, А. А., Lenskaya, K. V., & Vassiliev, P. M. (2015) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-015-1313-x · Cited by 7
Ferjancic, Z. B., & Saičić, R. N. (2021) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202100398 · Cited by 7
Concellón, J. M., Rivero, I. A., Rodríguez‐Solla, H., et al. (2008) · The Journal of Organic Chemistry · doi:10.1021/jo801058c · Cited by 7
Spanu, P., de Candia, C., & Ulgheri, F. (2010) · Tetrahedron Letters · doi:10.1016/j.tetlet.2010.02.093 · Cited by 7
Arora, I., & Shaw, A. K. (2016) · Tetrahedron · doi:10.1016/j.tet.2016.07.036 · Cited by 7
Iftikhar, M., Wang, L., & Fang, Z. (2017) · Journal of Chemical Research · doi:10.3184/174751917x15000341607489 · Cited by 7
Choi, Y. J., Kim, Y. C., Park, S. J., Jung, J. M., Kim, Y. S., Kim, I. S., & Jung, Y. H. (2017) · Tetrahedron · doi:10.1016/j.tet.2017.06.002 · Cited by 7
Sugar-derived Heterocycles and Their Precursors as Inhibitors Against Glycogen Phosphorylases (GP)
Khan, M. T. H. (2007) · Springer eBooks · doi:10.1007/7081_2007_067 · Cited by 6
Somsák, L., Bokor, É., Czifrák, K., Juhász, L., & Tóth, M. (2011) · InTech eBooks · doi:10.5772/23463 · Cited by 6
“Reversal of the spiro-configuration (compare Entries 1 and 5) as well as spiro-annelation of a six-membered ring (Entry 6) gave compounds with significantly weaker binding (Somsák et al., 2003).”
BackgroundResultInfluentialSelf-citationMallick, A., Pal, A. P. J., & Vankar, Y. D. (2013) · Tetrahedron Letters · doi:10.1016/j.tetlet.2013.09.102 · Cited by 6
Synthesis of (benzimidazol-2-yl)aniline derivatives as glycogen phosphorylase inhibitors
Galal, S. A., Khattab, M., Andreadaki, F. J., et al. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.08.069 · Cited by 6
Gajare, V. S., Khobare, S. R., Datrika, R., et al. (2015) · Tetrahedron Letters · doi:10.1016/j.tetlet.2015.10.013 · Cited by 5
Šimák, O., STANEK, J. J., & Moravcová, J. (2009) · Carbohydrate Research · doi:10.1016/j.carres.2009.03.016 · Cited by 5
Zhao, K., Zhou, G., Nie, H., & Chen, W. (2016) · Organic & Biomolecular Chemistry · doi:10.1039/c6ob01864e · Cited by 5
Synthesis of some O-, S- and N-glycosides of hept-2-ulopyranosonamides
Nagy, V., Czifrák, K., Bényei, A. C., et al. (2009) · Carbohydrate Research · doi:10.1016/j.carres.2009.02.011 · Cited by 5
Self-citationCzakó, Z., Juhász, L., Kenéz, Á., Czifrák, K., Somsák, L., Docsa, T., Gergely, P., & Antus, S. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.07.052 · Cited by 5
Self-citationLopez-Saura, P., & Herrera-Martínez, B. A.-C. L. (2013) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000285 · Cited by 6
Hamadi, N. B. (2020) · Current Organic Synthesis · doi:10.2174/1570179417666201217142634 · Cited by 4
Racine, E., Philouze, C., & Py, S. (2008) · Journal of Chemical Crystallography · doi:10.1007/s10870-008-9506-8 · Cited by 4
1-Isopropyl-4-nitro-6-methoxy-1H-benzimidazole
Moore, M. D., Jain, P., Flaherty, P. T., et al. (2008) · Acta Crystallographica Section E Structure Reports Online · doi:10.1107/s160053680801859x · Cited by 4
“…application in multiple biologically active compounds including ATP mimics (Townsend & Revankar, 1970, Kamal et al., 2006, Bentancor et al., 2004, Somsak et al., 2003, Scholz et al., 2003), ATPase inhibitors (Sachs et al., 1995, Shin et al., 1997), peptide mimics (Chackalamannil et al., 2003,…”
Pommier, M., & Vidal, S. (2019) · Topics in heterocyclic chemistry · doi:10.1007/7081_2019_33 · Cited by 4
López‐García, M. Á., Maya, I., Fernández‐Bolaños, J. G., et al. (2010) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201000540 · Cited by 3
One-Pot Synthesis of Pyrrolidine-2-ones from Erythruronolactone and Amine
Benhaoua, C. (2012) · Organic Chemistry International · doi:10.1155/2012/482952 · Cited by 3
RetractedVibrational spectroscopic and molecular docking study of 4-Methylphenylquinoline-2-carboxylate
Fazal, E., Panicker, C. Y., Varghese, H. T., et al. (2015) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2015.01.028 · Cited by 3
Kulkarni, M. G., Shaikh, Y. B., Birhade, D. R., Borhade, A. S., Chavhan, S. W., Dhondge, A. P., Gaikwad, D. D., & Dhatrak, N. R. (2012) · Tetrahedron Asymmetry · doi:10.1016/j.tetasy.2012.08.012 · Cited by 3
Model synthesis of six-membered carbocyclic spironucleosides
Nencka, R., Hřebabecký, H., & Dračínský, M. (2010) · Collection of Czechoslovak Chemical Communications · doi:10.1135/cccc2010103 · Cited by 3
Guesmi, A., El‐Fattah, W. A., Ticha, M. B., et al. (2022) · Current Organic Synthesis · doi:10.2174/1570179419666220420133644 · Cited by 2
Weaver, C. V., Turner, N., & Hall, J. L. (2012) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2012.06.002 · Cited by 2
Roy, R., Kancharla, P. K., Reddy, Y. S., Brar, A., & Vankar, Y. D. (2013) · Tetrahedron Asymmetry · doi:10.1016/j.tetasy.2013.09.021 · Cited by 2
Hassan, A. A., Jørgensen, P. T., Stein, P. C., et al. (2004) · Carbohydrate Research · doi:10.1016/j.carres.2004.03.022 · Cited by 2
Udry, G. A. O., Repetto, E., Vega, D. R., & Varela, O. J. (2017) · ChemistrySelect · doi:10.1002/slct.201701068 · Cited by 2
Iftikhar, M., & Fang, Z. (2017) · Journal of Carbohydrate Chemistry · doi:10.1080/07328303.2017.1397683 · Cited by 2
Evolution of the Total Syntheses of Batzellasides the First Marine Piperidine Iminosugar
Sengoku, T., Wierzejska, J., Takahashi, M., & Yoda, H. (2013) · Natural Product Communications · doi:10.1177/1934578x1300800729 · Cited by 2
“[23-25], this class of compound has been attracting a great deal of interest in the field of medicinal chemistry due to the promising therapeutic potential of the compounds as antidiabetic, antiviral and antitumor agents (Figure 3) [26-28].”
BackgroundHunter, K. S., Miller, A., Mentink‐Kane, M. M., & Davies, S. J. A. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.726465 · Cited by 3
Daskhan, G. C., Giri, M., & Jayaraman, N. (2017) · Springer eBooks · doi:10.1007/978-3-319-65587-1_6 · Cited by 1
Dandale, A. S., & Deshmukh, S. P. (2011) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-011-0636-5 · Cited by 1
Mavreas, K. F., Neofytos, D. D., Chrysina, E. D., et al. (2020) · Molecules · doi:10.3390/molecules25225463 · Cited by 1
Glycogen synthesis from dihydroxyacetone in isolated rat hepatocytes
Díaz‐Lobo, M., & Fernández-Novell, J. M. (2021) · Journal of Carbohydrate Chemistry · doi:10.1080/07328303.2021.1955129 · Cited by 1
Synthesis and reactivity of natural and unnatural carbohydrates
D’Alonzo, D. (2008) · Università degli Studi di Napoli Federico II · doi:10.6092/unina/fedoa/1977
Biochemical and molecular targets of novel antidiabetic agents
Singh, A. B. (2009) · INFLIBNET
Synthesis and Bioactivity of New Analogue of Bicyclic 1‐Azafagomine
Akhundova, F. N., Kurbanova, M., Huseynzada, A., et al. (2019) · ChemistrySelect · doi:10.1002/slct.201903190
Βιοχημικές μελέτες στο μεταβολισμό του γλυκογόνου
Κυριάκης, Ε. (2020) · doi:10.12681/eadd/47439
Ugi three-component coupling strategy for the synthesis of bridged bicyclic iminosugars
Rakesh, G., Vinaykumar, A., Soniya, D., et al. (2025) · Organic & Biomolecular Chemistry · doi:10.1039/d5ob01246e
Nistane, N. V., Gaikwad, S. B., & Puri, K. (2025) · International Journal of Scientific Research in Science and Technology · doi:10.32628/ijsrst25126400
Correa-Basurto, A. M., Valdés, M. Á. S., Pérez, L. C. C., Reyes-Vallejo, N., Cruz, A., Rosales‐Hernández, M. C., SALAZAR, J. A., & Mendieta‐Wejebe, J. E. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198863
Metadata
- Authors
- Somsak, L., Nagy, V., Hadady, Z., Docsa, T., & Gergely, P.
- Affiliations
- University of Debrecen (HU)
- Venue
- Current Pharmaceutical Design
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2003-06-01
- Volume
- 9
- Issue
- 15
- Pages
- 1177-1189
- ISSN
- 1381-6128 (ISSN-L)
- OpenAlex
- W2122174215
- Cited by
- 185
- References
- 0
- Citations by year
- 2026: 1 · 2025: 2 · 2023: 1 · 2022: 4 · 2021: 4 · 2020: 5 · 2019: 3 · 2018: 3 · 2017: 9 · 2016: 9 · 2015: 8 · 2014: 14 · 2013: 10 · 2012: 7
- FWCI
- 9.40
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- Current Pharmaceutical Design (publishedVersion)
- PubMed (publishedVersion)
- University of Debrecen Electronic Archive (University of Debrecen) (submittedVersion, other-oa)
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Keywords
- glycogen phosphorylase, antidiabetic drugs, type 2 diabetes, hydantoin derivatives, allosteric site, iminosugars, isofagomine, benzothiazole, benzimidazole, 1,3,4-oxadiazoles, tetrazoles, enzyme inhibition
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Enzyme Inhibitors, Glucose, Humans, Hypoglycemic Agents, Models, Molecular, Molecular Structure, Glycogen Phosphorylase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review